Search or choose
Find the right test or package.
PD-L1 (SP-142)
PD-L1 (SP-142) by IHC is an immunohistochemistry test that assesses the expression of programmed cell death ligand 1 (PD-L1) using the SP142 antibody. It helps identify the presence of PD-L1 in tumor tissues, aiding in the selection of patients who may benefit...
DiagnosticsLab test
Know more about this test
PD-L1 (SP-142) by IHC is an immunohistochemistry test that assesses the expression of programmed cell death ligand 1 (PD-L1) using the SP142 antibody. It helps identify the presence of PD-L1 in tumor tissues, aiding in the selection of patients who m...
Understanding PD-L1 (SP-142)
PD-L1 (SP-142) by IHC is an immunohistochemistry test that assesses the expression of programmed cell death ligand 1 (PD-L1) using the SP142 antibody. It helps identify the presence of PD-L1 in tumor tissues, aiding in the selection of patients who may benefit from immunotherapy, particularly in certain cancer treatments.
Disclaimer: In no event shall the liability of getAcure exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by getAcure.
What does PD-L1 (SP-142) measure?
PD-L1 (SP-142) by IHC is an immunohistochemistry test that assesses the expression of programmed cell death ligand 1 (PD-L1) using the SP142 antibody. It helps identify the presence of PD-L1 in tumor tissues, aiding in the selection of patients who may benefit from immunotherapy, particularly in certain cancer treatments.
Disclaimer: In no event shall the liability of getAcure exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by getAcure.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.